To assess Guglielmi detachable coil (GDC) embolisation in the treatment of patients with posterior circulation aneurysms. This included the type of lesions treated, the degree and durability of occlusion, and the short-term clinical outcome of the procedure. This abstract summarises the clinical outcomes, not the measures of technical success.
complications, morbidity and mortality. Data pertaining to the patients' independence status were dichotomised as independent (Rankin Scale 0-2, Glasgow Outcome Scale 1-2) or dependent (Rankin Scale 3-5, Glasgow Outcome Scale 3-4).
Methods of synthesis
How were the studies combined? Data from all of the included studies were given equal weight and pooled to obtain overall percentages for each outcome. Procedural mortality was analysed as a subset of total mortality within 30 days. The annual risk of SAH was calculated as the number of postembolisation haemorrhages divided by the total duration of follow-up (years). Treatment failures and patients lost to follow-up were not included when calculating the risk of SAH.
How were differences between studies investigated? Studies exclusive to the basilar apex were analysed separately from studies that included posterior circulation aneurysms at all locations (including the basilar apex).
Results of the review
Eighteen studies (1,024 patients, 728 aneurysms in the posterior circulation) met the inclusion criteria. Six of these studies were excluded from the analysis because of insufficient reporting of data. The remaining 12 studies (489 patients, 495 aneurysms in the posterior circulation) were analysed. Basilar apex (6 studies, 226 patients, 228 aneurysms).
Thirty-two (14%) patients experienced procedural complications, the most common of which were coil protrusion and parent vessel thrombosis. The non-procedural complications reported were cerebral vasospasm in 26 out of 154 SAH patients in four studies; hydrocephalus in 29 out of 76 patients in two studies; and pulmonary embolism and renal failure in one study. Procedural morbidity occurred in 15 (6.6%) patients; procedural mortality was 1.3% (3 patients). Overall, 10 patients died within 30 days (4.4%). There were three post-GDC SAH events among 221 patients representing 5,390.6 months of follow-up. The estimated annual risk of SAH after embolisation was 0.7%. The followup of 190 patients (representing 4,955.6 months of observation) found that 159 (83.7%) were independent, 13 were dependent and 18 had died.
Posterior circulation (6 studies, 263 patients, 267 aneurysms).
Thirty (11.2%) patients experienced procedural complications, the most common of which was parent vessel thrombosis. The non-procedural complications reported were cerebral vasospasm in 3 patients in three studies, and medical complications in 7 patients in two studies. Procedural morbidity occurred in 12 (4.5%) patients; procedural mortality was 1.5% (4 patients). Overall, 23 patients died within 30 days (8.6%). There were three post-GDC SAH events among 239 patients representing 4,018.8 months of follow-up. The estimated annual risk of SAH after embolisation was 0.9%. The follow-up of 260 patients (representing 4,018.8 months of observation) found that 223 (85.8%) were independent, 11 were dependent and 26 had died.
Data for the degree and durability of occlusion were available in the paper. language bias may have further increased the possibility that some relevant data were not identified. Rigorous methods to minimise bias in the study selection process and errors in the data extraction were not reported. The assessment of aspects of study quality gave an overall impression of the limitations of the data, which was probably the best use that could be made of the information on study quality in this particular review. Practitioners will need to decide whether the details provided on patient characteristics and aneurysms treated are sufficient to inform their clinical decisionmaking. The analysis was simply the sum of events across studies without a formal assessment of heterogeneity (differences) between the studies. This could hinder decision-making about applicability.
The evidence presented supports the authors' conclusion concerning unruptured aneurysms. The authors' conclusion concerning the prevention of early rebleeding from ruptured aneurysms appears to have been based largely on data from sources other than this review.
